Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
63,500
+1,600 (2.58%)
At close: Aug 28, 2025

Next Biomedical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
520,937331,554----
Upgrade
Enterprise Value
501,137316,300----
Upgrade
Last Close Price
64100.0041000.00----
Upgrade
PE Ratio
202.36115.95----
Upgrade
PS Ratio
42.8334.74----
Upgrade
PB Ratio
11.597.34----
Upgrade
P/TBV Ratio
11.677.39----
Upgrade
EV/Sales Ratio
41.2033.15----
Upgrade
Debt / Equity Ratio
0.260.240.700.566.25-0.37
Upgrade
Asset Turnover
-0.220.160.080.070.09
Upgrade
Inventory Turnover
-1.601.371.611.831.23
Upgrade
Quick Ratio
2.813.681.351.381.700.18
Upgrade
Current Ratio
3.073.951.571.591.820.24
Upgrade
Return on Equity (ROE)
-9.28%-41.64%-46.30%--
Upgrade
Return on Assets (ROA)
--5.05%-10.57%-10.03%-13.55%-12.52%
Upgrade
Return on Capital (ROIC)
--5.31%-11.14%-10.68%-64.38%-4371.23%
Upgrade
Earnings Yield
0.49%0.86%----
Upgrade
FCF Yield
-0.85%-0.50%----
Upgrade
Buyback Yield / Dilution
-29.11%-17.78%-1.10%-28.34%-13.05%-199.99%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.